A Dose Finding and Safety Study of CC-220, Alone and in Combination With an Anti-CD20 Monoclonal Antibody (mAb) in Subjects With Relapsed or Refractory Lymphomas

Local Institution - 402, Leipzig

Local Institution - 500, Seoul

Local Institution - 100, New York

Local Institution - 401, Berlin

University of Rochester Cancer Center, Rochester

Local Institution - 303, Milan

Local Institution - 300, Brescia

Local Institution - 301, Pavia

Local Institution - 105, Lake Mary

Local Institution - 601, Taoyuan

Local Institution - 205, Pessac

Local Institution - 201, Montpellier

Local Institution - 302, Verona

Local Institution - 103, Nashville

Local Institution - 602, Taoyuan

Local Institution - 202, Nantes

Local Institution - 403, Münster

Local Institution - 102, Rochester

Local Institution - 200, Lillie Cedex

Local Institution - 204, Paris

Local Institution - 600, Niaosong District Kaohsiung City

Local Institution - 106, Phoenix

Local Institution - 203, Créteil

Local Institution - 404, Würzburg

Local Institution - 502, Seoul

Local Institution - 501, Seoul